Insider filing · IMVT
Douglas J. Hughes
Director
profile →
Immunovant, Inc.
IMVT · Healthcare · 35 filings in 24 months
ticker →
Douglas J. Hughes sold $303K of Immunovant (IMVT)
Executed Dec 1 2025, disclosed Dec 3 2025, 2 days later.
Value, as filed
$303K
13,091 sh × $23.14
Executed
Dec 1 2025
the trade date, as filed
Disclosed
Dec 3 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
DHDouglas J. Hughes (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Immunovant, Inc. (IMVT). The largest single filing was $303K of IMVT (13,091 sh × $23.14, as filed), executed Dec 1 2025.
The name
IMVTHealthcare · Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Douglas J. Hughes in IMVT
IMVTSALE
Immunovant, Inc.
$155K5,425 sh × $28.54
Exec Dec 2 2024
Filed Dec 4 2024 · 5:30 PM ET